By
Drug Target Review2025-08-06T10:40:09
Scientists at Ghent University have discovered that a simple combination of vitamin B1 and glucose could drastically improve survival in sepsis – a life-threatening condition responsible for millions of deaths each year.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2023-05-31T15:16:10
Sponsored by Bio-Techne
2023-03-07T10:55:58
Sponsored by Agilent
2023-04-17T14:45:00
Sponsored by Sartorius, By Drug Target Review
2023-07-11T16:13:06
Sponsored by Agilent
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2023-02-03T13:56:13
Sponsored by Leica Microsystems
Site powered by Webvision Cloud